AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors

ABSTRACT:

Background

There have been no specific serum biomarkers for thymic epithelial tumors (TETs) yet. The study aimed to explore the diagnostic and prognostic value of potentially relevant serum tumor markers in TETs.

Methods

We retrospectively analyzed the database of our own with the aim of reviewing the clinical records of 301 patients who have a thymic epithelial tumor after radical thymectomy, in the period between November 2012 and December 2017. Logistic regression analysis was used to evaluate relationships between tumor markers and tumor characteristics. Cox regression analysis and Kaplan Meier analysis were used to evaluate free-from-recurrence (FFR) in complete resected (R0) patients.

Results

There were 231 (76.7%) thymoma patients, 70 (23.3%) thymic carcin

SUBMITTER:  

PROVIDER: S-EPMC9792826 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature